CANbridge Life Sciences
Latest round
- Series E
Last raised
- Dec 2020
Total raised
- $214M
Investors
- 19
About CANbridge Life Sciences
Established in 2012 and based in Beijing, China, CANbridge Life Sciences, Ltd. operates as a biopharmaceutical company that develops drug candidates and other healthcare products for serious and critical medical conditions. Founder Dr. Xue Qunis the CEO and formerly an executive of Genzyme in the United States and the first general manager of Genzyme China. The company focuses on the development of cutting-edge technology fields such as innovative bio-targeted drugs for malignant tumors and precision treatments represented by rare diseases. The company is committed to accelerating the development and commercialization of innovative therapies for rare diseases and rare tumors in China and globally to fill the unmet medical needs.
Who invested in CANbridge Life Sciences
19 investors across 6 rounds
See all investors in CANbridge Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CANbridge Life Sciences
Who invested in CANbridge Life Sciences?
CANbridge Life Sciences has 19 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CANbridge Life Sciences raised?
CANbridge Life Sciences has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did CANbridge Life Sciences last raise money?
CANbridge Life Sciences's most recent round on record is a Series E, in Dec 2020.
What does CANbridge Life Sciences do?
Established in 2012 and based in Beijing, China, CANbridge Life Sciences, Ltd.
Where is CANbridge Life Sciences headquartered?
CANbridge Life Sciences is headquartered in Beijing, China.
Which VCs invest in companies like CANbridge Life Sciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CANbridge Life Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like CANbridge Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.